Target Name: MIR3652
NCBI ID: G100500842
Review Report on MIR3652 Target / Biomarker Content of Review Report on MIR3652 Target / Biomarker
MIR3652
Other Name(s): hsa-miR-3652 | hsa-mir-3652 | microRNA 3652 | MicroRNA 3652

MIR3652: A Potential Drug Target and Biomarker

MIR3652 is a small molecule inhibitor of the enzyme IDH, which is responsible for the production of the protein DAPI3. IDH is a key regulator of cell proliferation and is often aberrantly expressed in various types of cancer. MIR3652 has been shown to be a highly effective inhibitor of IDH, with a 100% inhibition of IDH activity at concentrations that are typically used to treat cancer.

In addition to its potential as an IDH inhibitor, MIR3652 has also been shown to have a variety of other biological effects. For example, it has been shown to reduce inflammation and oxidation in cancer cells, and to promote cell apoptosis (programmed cell death) in cancer cells. These effects may be due to MIR3652's ability to modulate the activity of multiple cellular signaling pathways, including those involved in cell cycle progression, apoptosis, and inflammation.

MIR3652 has also been shown to have a unique mechanism of action. Unlike many other IDH inhibitors, which inhibit the enzyme directly, MIR3652 appears to work by binding to a different site on the IDH protein. This binding appears to cause a conformational change in the IDH molecule, which allows it to interact with and inhibit the activity of the enzyme.

The potential clinical applications of MIR3652 are vast. As an IDH inhibitor, it has the potential to be used as a treatment for a variety of cancers, including pancreatic, ovarian, and breast cancers. It has also been shown to be particularly effective against theIDH-positive tumors known as castration-resistant prostate cancer (CRPC), and may have a similar impact on other types of CRPC.

In addition to its potential use as a cancer treatment, MIR3652 may also have a variety of other applications. For example, it has been shown to have a beneficial effect on the development and progression of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. It has also been shown to have a positive effect on skin health and may have potential as a treatment for skin diseases.

The development of MIR3652 as a drug target and biomarker is an exciting and promising direction for research. Further studies are needed to fully understand the mechanism of MIR3652's activity and its potential clinical applications. However, the potential of MIR3652 as an IDH inhibitor and biomarker makes it a valuable tool for the development of new cancer treatments.

Protein Name: MicroRNA 3652

The "MIR3652 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3652 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR3654 | MIR3655 | MIR3658 | MIR3659 | MIR365A | MIR365B | MIR3660 | MIR3661 | MIR3662 | MIR3663 | MIR3664 | MIR3665 | MIR3667 | MIR3667HG | MIR3668 | MIR367 | MIR3670-1 | MIR3670-2 | MIR3671 | MIR3672 | MIR3674 | MIR3675 | MIR3677 | MIR3678 | MIR3679 | MIR3680-1 | MIR3680-2 | MIR3681 | MIR3681HG | MIR3682 | MIR3683 | MIR3685 | MIR3686 | MIR3687 | MIR3688-1 | MIR3688-2 | MIR3689A | MIR3689B | MIR3689C | MIR3689D1 | MIR3689D2 | MIR3689F | MIR369 | MIR3690 | MIR3691 | MIR3692 | MIR370 | MIR3713 | MIR3714 | MIR371A | MIR371B | MIR372 | MIR373 | MIR374A | MIR374B | MIR374C | MIR375 | MIR376A1 | MIR376A2 | MIR376B | MIR376C | MIR377 | MIR378A | MIR378B | MIR378C | MIR378D1 | MIR378D2 | MIR378E | MIR378F | MIR378G | MIR378H | MIR378I | MIR379 | MIR380 | MIR381 | MIR382 | MIR383 | MIR384 | MIR3907 | MIR3908 | MIR3909 | MIR3910-1 | MIR3910-2 | MIR3911 | MIR3912 | MIR3913-1 | MIR3913-2 | MIR3914-1 | MIR3914-2 | MIR3915 | MIR3916 | MIR3917 | MIR3918 | MIR3919 | MIR3920 | MIR3921 | MIR3922 | MIR3923 | MIR3924 | MIR3925